Volume 21, Number 9—September 2015
Dispatch
Acute Respiratory Infections in Travelers Returning from MERS-CoV–Affected Areas
Table
Pathogen† | Case count |
||
---|---|---|---|
No. (%)‡ | Highest no. imported in 1 mo | Time of highest no. | |
Influenza viruses | |||
Influenza A (H3) virus | 14 (7.9) | 7 | 2013 Oct |
Influenza A(H1N1)pdm09 virus | 13 (7.3) | 4 | 2014 May |
Influenza B virus |
14 (7.9) |
6 |
2014 May |
Other respiratory viruses | |||
Rhinovirus | 35 (19.8) | 10 | 2013 Oct |
Parainfluenza viruses 1–4 | 5 (2.8) | 1 | NA |
Human metapneumovirus | 4 (2.6) | 2 | 2014 May |
Respiratory syncytial virus (A and B) | 4 (2.6) | 1 | NA |
Enterovirus | 1 (0.6) | NA | NA |
Adenovirus | 1 (0.6) | NA | NA |
Bocavirus |
0 |
NA |
NA |
Human CoVs | |||
Human CoV OC43 | 6 (3.4) | 3 | 2014 Feb |
Human CoV 229E/NL63 | 2 (1.1) | 1 | NA |
MERS-CoV |
0 |
NA |
NA |
Bacteria | |||
Chlamydophila pneumoniae | 1 (0.6) | NA | NA |
Legionella spp. | 1 (0.6) | NA | NA |
Mycoplasma pneumoniae | 0 | NA | NA |
*CoV, coronavirus; MERS, Middle East respiratory virus; NA, not applicable.
†Among the 177 returned travelers, no respiratory pathogen was found for 88 (49.7%). Among the remaining 89 (50.3%) returned travelers, at least 1 respiratory pathogen was found; 12 (6.8%) of these persons had viral co-infections. Among the 12 co-infections were 8 rhinovirus co-infections (4 persons with influenza A and 1 each with influenza B, enterovirus, CoV OC43, parainfluenza); 1 influenza A–CoV OC43 co-infection; 1 influenza B–respiratory syncytial virus; 1 CoV 229E/NL63–adenovirus; and 1 CoV 229E/NL63–human metapneumovirus co-infection.
‡Comprises all reported infections, including viruses that were involved in co-infections.
1Current affiliation: St. Michael’s Hospital, Toronto, Ontario, Canada.